159 related articles for article (PubMed ID: 31029521)
1. Growth-differentiation factor-15 predicts adverse cardiac events in patients with acute coronary syndrome: A meta-analysis.
Wang Y; Zhen C; Wang R; Wang G
Am J Emerg Med; 2019 Jul; 37(7):1346-1352. PubMed ID: 31029521
[TBL] [Abstract][Full Text] [Related]
2. Growth differentiation factor-15 predicts the prognoses of patients with acute coronary syndrome: a meta-analysis.
Zhang S; Dai D; Wang X; Zhu H; Jin H; Zhao R; Jiang L; Lu Q; Yi F; Wan X; Cui H
BMC Cardiovasc Disord; 2016 May; 16():82. PubMed ID: 27154403
[TBL] [Abstract][Full Text] [Related]
3. Convalescent Growth Differentiation Factor-15 and Long-Term Outcomes after an Acute Coronary Syndrome.
Greer CE; Chew-Harris J; Adamson PD; Pemberton CJ; Pickering JW; Pilbrow AP; Frampton CM; Troughton RW; Doughty RN; Richards AM
J Appl Lab Med; 2024 Jul; 9(4):672-683. PubMed ID: 38635817
[TBL] [Abstract][Full Text] [Related]
4. Long-term prognostic value of growth differentiation factor-15 in acute coronary syndromes.
Peiró ÓM; García-Osuna Á; Ordóñez-Llanos J; Cediel G; Bonet G; Rojas S; Quintern V; Bardají A
Clin Biochem; 2019 Nov; 73():62-69. PubMed ID: 31369736
[TBL] [Abstract][Full Text] [Related]
5. Growth-differentiation factor 15 for long-term prognostication in patients with non-ST-elevation acute coronary syndrome: an Invasive versus Conservative Treatment in Unstable coronary Syndromes (ICTUS) substudy.
Damman P; Kempf T; Windhausen F; van Straalen JP; Guba-Quint A; Fischer J; Tijssen JG; Wollert KC; de Winter RJ; Hirsch A;
Int J Cardiol; 2014 Mar; 172(2):356-63. PubMed ID: 24502880
[TBL] [Abstract][Full Text] [Related]
6. GROWTH DIFFERENTIATION FACTOR 15 AS A PROGNOSTIC MARKER OF CHRONIC HEART FAILURE PROGRESSION IN LONG-TERM FOLLOW-UP AFTER ACUTE CORONARY SYNDROME.
Kopytsya M; Vyshnevska I; Protsenko O; Barahmeh H
Georgian Med News; 2017 Oct; (271):61-66. PubMed ID: 29099703
[TBL] [Abstract][Full Text] [Related]
7. Biomarkers and Coronary Lesions Predict Outcomes after Revascularization in Non-ST-Elevation Acute Coronary Syndrome.
Lindholm D; James SK; Bertilsson M; Becker RC; Cannon CP; Giannitsis E; Harrington RA; Himmelmann A; Kontny F; Siegbahn A; Steg PG; Storey RF; Velders MA; Weaver WD; Wallentin L;
Clin Chem; 2017 Feb; 63(2):573-584. PubMed ID: 27932413
[TBL] [Abstract][Full Text] [Related]
8. Growth-differentiation factor 15 as a predictor of mortality in patients with heart failure: a meta-analysis.
Zeng X; Li L; Wen H; Bi Q
J Cardiovasc Med (Hagerstown); 2017 Feb; 18(2):53-59. PubMed ID: 27454651
[TBL] [Abstract][Full Text] [Related]
9. Serial bedside B-type natriuretic peptide strongly predicts prognosis in acute coronary syndrome independent of echocardiographic abnormalities.
Ang DS; Kong CF; Kao MP; Struthers AD
Am Heart J; 2009 Jul; 158(1):133-40. PubMed ID: 19540403
[TBL] [Abstract][Full Text] [Related]
10. [Correlation between levels of serum growth differentiation factor-15 and acute coronary syndrome].
Zheng LB; Guo YH; Yu HY; Mi L; Wang YP; Gao W
Beijing Da Xue Xue Bao Yi Xue Ban; 2011 Apr; 43(2):250-4. PubMed ID: 21503121
[TBL] [Abstract][Full Text] [Related]
11. Prognostic Role of Elevated Myeloperoxidase in Patients with Acute Coronary Syndrome: A Systemic Review and Meta-Analysis.
Kolodziej AR; Abo-Aly M; Elsawalhy E; Campbell C; Ziada KM; Abdel-Latif A
Mediators Inflamm; 2019; 2019():2872607. PubMed ID: 31341419
[TBL] [Abstract][Full Text] [Related]
12. Growth-differentiation factor-15 for risk stratification in patients with stable and unstable coronary heart disease: results from the AtheroGene study.
Kempf T; Sinning JM; Quint A; Bickel C; Sinning C; Wild PS; Schnabel R; Lubos E; Rupprecht HJ; Münzel T; Drexler H; Blankenberg S; Wollert KC
Circ Cardiovasc Genet; 2009 Jun; 2(3):286-92. PubMed ID: 20031597
[TBL] [Abstract][Full Text] [Related]
13. Growth differentiation factor 15 and cardiovascular events in patients with stable ischemic heart disease (The Heart and Soul Study).
Schopfer DW; Ku IA; Regan M; Whooley MA
Am Heart J; 2014 Feb; 167(2):186-192.e1. PubMed ID: 24439979
[TBL] [Abstract][Full Text] [Related]
14. Growth differentiation factor-15 and risk of recurrent events in patients stabilized after acute coronary syndrome: observations from PROVE IT-TIMI 22.
Bonaca MP; Morrow DA; Braunwald E; Cannon CP; Jiang S; Breher S; Sabatine MS; Kempf T; Wallentin L; Wollert KC
Arterioscler Thromb Vasc Biol; 2011 Jan; 31(1):203-10. PubMed ID: 20966402
[TBL] [Abstract][Full Text] [Related]
15. The role of growth differentiation factor 15 as a predictor of 5-year survival of patients after acute coronary syndrome.
Vyshnevska IR; Kopytsya MP; Kutya IM; Protsenko OS
Pol Merkur Lekarski; 2020 Oct; 48(287):297-301. PubMed ID: 33130786
[TBL] [Abstract][Full Text] [Related]
16. Growth differentiation factor-15 as a prognostic marker in patients with acute myocardial infarction.
Khan SQ; Ng K; Dhillon O; Kelly D; Quinn P; Squire IB; Davies JE; Ng LL
Eur Heart J; 2009 May; 30(9):1057-65. PubMed ID: 19168526
[TBL] [Abstract][Full Text] [Related]
17. Usefulness of Elevated Levels of Growth Differentiation Factor-15 to Classify Patients With Acute Coronary Syndrome Having Percutaneous Coronary Intervention Who Would Benefit from High-Dose Statin Therapy.
Tentzeris I; Farhan S; Freynhofer MK; Rohla M; Jarai R; Vogel B; Baumgartner-Parzer S; Nürnberg M; Geppert A; Wessely E; Wojta J; Huber K; Kautzky-Willer A
Am J Cardiol; 2017 Sep; 120(5):747-752. PubMed ID: 28734463
[TBL] [Abstract][Full Text] [Related]
18. Growth Differentiation Factor 15 at 1 Month After an Acute Coronary Syndrome Is Associated With Increased Risk of Major Bleeding.
Lindholm D; Hagström E; James SK; Becker RC; Cannon CP; Himmelmann A; Katus HA; Maurer G; López-Sendón JL; Steg PG; Storey RF; Siegbahn A; Wallentin L
J Am Heart Assoc; 2017 Apr; 6(4):. PubMed ID: 28411246
[TBL] [Abstract][Full Text] [Related]
19. Troponin elevations only detected with a high-sensitivity assay: clinical correlations and prognostic significance.
Korley FK; Schulman SP; Sokoll LJ; DeFilippis AP; Stolbach AI; Bayram JD; Saheed MO; Omron R; Fernandez C; Lwin A; Cai SS; Post WS; Jaffe AS
Acad Emerg Med; 2014 Jul; 21(7):727-35. PubMed ID: 25112512
[TBL] [Abstract][Full Text] [Related]
20. Short-term and long-term prognostic value of circulating soluble suppression of tumorigenicity-2 concentration in acute coronary syndrome: a meta-analysis.
Gu L; Li J
Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31092701
[No Abstract] [Full Text] [Related]
[Next] [New Search]
